Digital Diabetes Management Market Size - By Product Type (Devices, Services), By Patient Type (Type 1, Type 2), By End-Use (Hospitals, Home Settings, Diagnostic Centers & Clinics) - Global Forecast to 2032

Digital Diabetes Management Market Size - By Product Type (Devices, Services), By Patient Type (Type 1, Type 2), By End-Use (Hospitals, Home Settings, Diagnostic Centers & Clinics) - Global Forecast to 2032

Digital Diabetes Management Market Size

Digital Diabetes Management Market size was worth USD 18.9 billion in 2022. Driven by the rising prevalence of diabetes globally, the industry could grow at 20% CAGR from 2023 to 2032.

Growing adoption of a sedentary lifestyle, poor eating habits, and rising cases of obesity have increased the occurrence of diabetes, increasing the demand for digital diabetes management for remote patient monitoring. As per the International Diabetes Federation, in 2021, the global diabetes prevalence in people aged between 20 to 79 years was 10.5% (536.6 million people), which is projected to reach around 783 million people by 2045.

COVID-19 Impact

The COVID-19 pandemic asserted a profound impact on the digital diabetes management market. The high susceptibility of diabetes patients to COVID1-9 infection increased the demand for remote patient monitoring devices for continued disease monitoring. Many government authorities across the globe also granted emergency use authorization for diabetes care devices. For instance, the U.S. FDA rolled out the guidance for permitting home-based blood glucose meters in hospitals. Such initiatives further helped strengthen the market outlook during the crisis.

Digital Diabetes Management Market Trends

The advent of big data analytics and AI in diabetes devices will create ample opportunities for the market. AI technology has gained immense traction in insulin monitoring, insulin injection guidance, diabetes prediction, and exercise guidance in diabetes management. Moreover, a remarkable growth in AI technology is helping healthcare providers get access to large data sets of diabetes patients. This high availability of information is helping patients get customized treatment for enhanced clinical outcomes thus, stimulating industry revenue streams.

Digital Diabetes Management Market Analysis

Based on product, Digital diabetes management market share from the services segment will grow at over 18.5% CAGR from 2023 to 2032. Rapid advancements in diabetes management apps and software will present new pathways for segment growth. Some diabetes management apps can now integrate fitness trackers and wearable medical devices, such as smartwatches and activity monitors. This integration allows individuals to track their physical activity levels, monitor their heart rate, and estimate the impact of exercise on their blood sugar levels.
 

With respect to end-use, the digital diabetes management market size from the hospitals segment reached over USD 7 billion in 2022. Growing usage of digital technologies for remote patient monitoring in hospitals will contribute to segment growth. Moreover, the high availability of advanced digital diabetes management tools, such as insulin delivery devices, has increased patient visits to these facilities. Many governments across the globe also granted approval for a few digital diabetes management products in hospitals during COVID-19, thereby augmenting segment gains.
 

On the regional front, North America digital diabetes management market will grow at over 19% CAGR between 2023 and 2032. Growing prevalence of diabetes has increased the need for diabetes care devices in the region. Supportive government initiatives for the treatment of the disease are creating a favorable growth outlook for the regional industry. In fact, in November 2021, the government of Canada and partners announced an investment of USD 20 million in new diabetes research teams for the treatment of people living with diabetes.
 

Digital Diabetes Management Market Share

• Ypsomed Holding
• Tidepool
• DarioHealth Corporation
• Pendiq
• Ascensia Diabetes Care Holdings Ag
• Glooko Inc
•  Novo Nordisk A/S
   

Digital Diabetes Management Industry News

• In May 2023, Medtronic plc, a global leader in healthcare technology, announced definitive agreements for the acquisition of EOFlow Co. Ltd., manufacturer of wearable insulin patches to offer the benefits of automated insulin delivery and simplify diabetes treatment. This acquisition will help strengthen the company’s industry position while broadening its product portfolio.
   
• In April 2023, Glooko, Inc., a prominent software company, inked a Global partnership deal with Hedia, an insulin dosing algorithm company, to offer an interoperable solution that integrates remote patient monitoring, connected care, and digital therapeutic technologies to increase access to people with Type 1 and Type 2 diabetes in need of bolus insulin dosing advice.
   

The digital diabetes management market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

Market Size, By Product

• Devices
  • By device
    • Smart blood glucose meters
    • Smart CGM
    • Smart insulin pumps & patches
    • Smart insulin pens
  • By device type
    • Handheld
    • Wearable
• Services
  • Software
  • Apps

Market Size, By Patient

• Type 1
• Type 2

Market Size, By End-use

• Hospital
• Home settings
• Diagnostic centers & clinics
• Others

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE